Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Tofacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,709Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US
    Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US

    08 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218407

    FDA
    08 Oct 2025
    Share Share
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence

    24 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241024256878/en

    BUSINESSWIRE
    24 Oct 2024
    Share Share
    Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event
    Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915229/0/en/Biora-Therapeutics-Announces-Supplemental-Data-from-Phase-1-Clinical-Trial-of-BT-600-as-Presented-at-KOL-Event.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results
    Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909602/0/en/Biora-Therapeutics-to-Host-Virtual-KOL-Event-on-NaviCap-Targeted-Oral-Delivery-Platform-and-Results-from-Phase-1-Clinical-Trial-of-BT-600-on-July-17-2024.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share
    Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
    Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

    01 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/01/2906658/0/en/Biora-Therapeutics-Announces-Positive-Clinical-Trial-Results-for-BT-600.html

    GLOBENEWSWIRE
    01 Jul 2024
    Share Share
    Aurobindo 's Generic Betamethasone Dipropionate Receives Approval in the U.S
    Aurobindo 's Generic Betamethasone Dipropionate Receives Approval in the U.S

    04 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218462

    FDA
    04 Jun 2024
    Share Share